Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients

Alexander Breitenstein1, Martina Glanzmann2, Volkmar Falk3

  • 1Cardiology, University Heart Center, University Hospital Zurich, Switzerland; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland; Center for Integrative Human Physiology (ZHIP), University of Zurich, Switzerland; Department of Electrophysiology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.

Insights

Atrial fibrillation (AF) patients show increased prothrombotic and proinflammatory markers in left atrial appendage (LAA) endocardium compared to the right (RAA). This finding explains LAA clot formation and thromboembolic risks in AF.

Area of Science:

  • Cardiovascular Biology
  • Thrombosis Research
  • Cellular and Molecular Medicine

Background:

  • Atrial fibrillation (AF) increases thromboembolic event risk.
  • Left atrial appendage (LAA) is a primary site for clot formation in AF.
  • Mechanisms of LAA clot formation are poorly understood due to challenges in cell isolation and culture.

Purpose of the Study:

  • To investigate the prothrombotic and proinflammatory profile of endocardial cells from LAA and RAA in AF patients.
  • To establish a novel protocol for isolating and culturing atrial appendage endocardial cells.

Main Methods:

  • Endocardial cells were isolated and cultured from LAA and RAA of AF patients undergoing cardiac surgery.
  • Cells were stimulated with TNF-α to analyze prothrombotic and proinflammatory marker expression.
  • Flow cytometry (FACS) was used to confirm cell purity and analyze marker expression.

Main Results:

  • A novel protocol successfully isolated and cultured LAA endocardial cells with 98% purity.
  • TNF-α stimulation significantly increased tissue factor (TF) and PAI-1 expression in LAA cells.
  • VCAM-1 expression was significantly higher in LAA endocardial cells compared to RAA cells.

Conclusions:

  • The LAA endocardium in AF patients exhibits a heightened prothrombotic and proinflammatory profile.
  • This enhanced profile in LAA endocardium may explain its propensity for clot formation.
  • Findings suggest novel therapeutic targets for preventing LAA-related thromboembolic complications in AF.
Abstract